Literature DB >> 29483078

Point-of-care urine culture for managing urinary tract infection in primary care: a randomised controlled trial of clinical and cost-effectiveness.

Christopher C Butler1, Nick A Francis2, Emma Thomas-Jones3, Mirella Longo2, Mandy Wootton4, Carl Llor5, Paul Little6, Michael Moore6, Janine Bates3, Timothy Pickles3, Nigel Kirby3, David Gillespie3, Kate Rumsby6, Curt Brugman7, Micaela Gal2, Kerenza Hood3, Theo Verheij7.   

Abstract

BACKGROUND: The effectiveness of using point-of-care (POC) urine culture in primary care on appropriate antibiotic use is unknown. AIM: To assess whether use of the Flexicult™ SSI-Urinary Kit, which quantifies bacterial growth and determines antibiotic susceptibility at the point of care, achieves antibiotic use that is more often concordant with laboratory culture results, when compared with standard care. DESIGN AND
SETTING: Individually randomised trial of females with uncomplicated urinary tract infection (UTI) in primary care research networks (PCRNs) in England, the Netherlands, Spain, and Wales.
METHOD: Multilevel regression compared outcomes between the two groups while controlling for clustering.
RESULTS: In total, 329 participants were randomised to POC testing (POCT) and 325 to standard care, and 324 and 319 analysed. Fewer females randomised to the POCT arm than those who received standard care were prescribed antibiotics at the initial consultation (267/324 [82.4%] versus 282/319 [88.4%], odds ratio [OR] 0.56, 95% confidence interval [CI] = 0.35 to 0.88). Clinicians indicated the POCT result changed their management for 190/301 (63.1%). Despite this, there was no statistically significant difference between study arms in antibiotic use that was concordant with laboratory culture results (primary outcome) at day 3 (39.3% POCT versus 44.1% standard care, OR 0.84, 95% CI = 0.58 to 1.20), and there was no evidence of any differences in recovery, patient enablement, UTI recurrences, re-consultation, antibiotic resistance, and hospitalisations at follow-up. POCT culture was not cost-effective.
CONCLUSION: Point-of-care urine culture was not effective when used mainly to adjust immediate antibiotic prescriptions. Further research should evaluate use of the test to guide initiation of 'delayed antibiotics'. © British Journal of General Practice 2018.

Entities:  

Keywords:  antimicrobial drug resistance; bacterial infections; cost–benefit analysis; drug resistance; point-of-care testing; urinary tract infections

Mesh:

Substances:

Year:  2018        PMID: 29483078      PMCID: PMC5863681          DOI: 10.3399/bjgp18X695285

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  31 in total

Review 1.  Assessing the value of diagnostic tests: a framework for designing and evaluating trials.

Authors:  Lavinia Ferrante di Ruffano; Christopher J Hyde; Kirsten J McCaffery; Patrick M M Bossuyt; Jonathan J Deeks
Journal:  BMJ       Date:  2012-02-21

2.  Analytic laboratory performance of a point of care urine culture kit for diagnosis and antibiotic susceptibility testing.

Authors:  E Bongard; N Frimodt-Møller; M Gal; M Wootton; R Howe; N Francis; H Goossens; C C Butler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-06       Impact factor: 3.267

Review 3.  Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis.

Authors:  Céire Costelloe; Chris Metcalfe; Andrew Lovering; David Mant; Alastair D Hay
Journal:  BMJ       Date:  2010-05-18

4.  Validating the prediction of lower urinary tract infection in primary care: sensitivity and specificity of urinary dipsticks and clinical scores in women.

Authors:  Paul Little; Sheila Turner; Kate Rumsby; Rachel Jones; Greg Warner; Michael Moore; J Andrew Lowes; Helen Smith; Catherine Hawke; Geraldine Leydon; Mark Mullee
Journal:  Br J Gen Pract       Date:  2010-07       Impact factor: 5.386

Review 5.  Urinary tract infections in women.

Authors:  Stefano Salvatore; Silvia Salvatore; Elena Cattoni; Gabriele Siesto; Maurizio Serati; Paola Sorice; Marco Torella
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-02-23       Impact factor: 2.435

6.  Clinical evaluation of a novel chromogenic agar dipslide for diagnosis of urinary tract infections.

Authors:  P Yagupsky; M Rider; N Peled
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-09       Impact factor: 3.267

7.  Uricult and Sensicult dipslides for diagnosis of bacteriuria and prediction of drug resistance in primary health care.

Authors:  S Ferry; L G Burman; S E Holm
Journal:  Scand J Prim Health Care       Date:  1989-06       Impact factor: 2.581

8.  Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women.

Authors:  T C M Christiaens; M De Meyere; G Verschraegen; W Peersman; S Heytens; J M De Maeseneer
Journal:  Br J Gen Pract       Date:  2002-09       Impact factor: 5.386

9.  Decision making by general practitioners in diagnosis and management of lower urinary tract symptoms in women.

Authors:  I Nazareth; M King
Journal:  BMJ       Date:  1993-04-24

10.  Clinical management of urinary tract infection in women: a prospective cohort study.

Authors:  Tom Fahey; Emma Webb; Alan A Montgomery; Robert S Heyderman
Journal:  Fam Pract       Date:  2003-02       Impact factor: 2.267

View more
  7 in total

Review 1.  A systematic review of the outcomes reported in the treatment of uncomplicated urinary tract infection clinical trials.

Authors:  Sinead Duane; Claire Beecher; Akke Vellinga; Andrew W Murphy; Martin Cormican; Andrew Smyth; Patricia Healy; Michael Moore; Paul Little; Declan Devane
Journal:  JAC Antimicrob Resist       Date:  2022-03-22

2.  A new point-of-care test for the rapid detection of urinary tract infections.

Authors:  Alyexandra Arienzo; Valentina Cellitti; Valeria Ferrante; Francesca Losito; Ottavia Stalio; Lorenza Murgia; Rossella Marino; Flavia Cristofano; Michela Orrù; Paolo Visca; Salvatore Di Somma; Lorena Silvestri; Vincenzo Ziparo; Giovanni Antonini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-09       Impact factor: 3.267

3.  Identification of clinical and urine biomarkers for uncomplicated urinary tract infection using machine learning algorithms.

Authors:  Amal A H Gadalla; Ida M Friberg; Ann Kift-Morgan; Jingjing Zhang; Matthias Eberl; Nicholas Topley; Ian Weeks; Simone Cuff; Mandy Wootton; Micaela Gal; Gita Parekh; Paul Davis; Clive Gregory; Kerenza Hood; Kathryn Hughes; Christopher Butler; Nick A Francis
Journal:  Sci Rep       Date:  2019-12-23       Impact factor: 4.379

4.  Exploiting open source 3D printer architecture for laboratory robotics to automate high-throughput time-lapse imaging for analytical microbiology.

Authors:  Sarah H Needs; Tai The Diep; Stephanie P Bull; Anton Lindley-Decaire; Partha Ray; Alexander D Edwards
Journal:  PLoS One       Date:  2019-11-19       Impact factor: 3.240

5.  Antibiotic procurement and ABC analysis for a comprehensive primary health care clinic in the Eastern Cape province, South Africa.

Authors:  Samridhi Sharma; Roman Tandlich; Mohamed Docrat; Sunitha Srinivas
Journal:  S Afr J Infect Dis       Date:  2020-11-25

Review 6.  A systematic review investigating the use of microbiology outcome measures in randomized controlled trials evaluating antimicrobial stewardship interventions published between 2011 and 2021.

Authors:  Tin Man Mandy Lau; Rhian Daniel; Kathryn Hughes; Mandy Wootton; Kerry Hood; David Gillespie
Journal:  JAC Antimicrob Resist       Date:  2022-02-24

7.  Economic evaluation of antimicrobial stewardship in primary care: a systematic review and quality assessment.

Authors:  Befikadu L Wubishet; Gregory Merlo; Nazanin Ghahreman-Falconer; Lisa Hall; Tracy Comans
Journal:  J Antimicrob Chemother       Date:  2022-08-25       Impact factor: 5.758

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.